James Nisco - Apr 15, 2024 Form 3 Insider Report for LISATA THERAPEUTICS, INC. (LSTA)

Role
Senior Vice President, Finance and Treasury and Chief Accounting Officer Exhibit 24.1 - Power of Attorney
Signature
/s/ James Nisco
Stock symbol
LSTA
Transactions as of
Apr 15, 2024
Transactions value $
$0
Form type
3
Date filed
4/24/2024, 08:59 PM
Next filing
Oct 2, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding LSTA Common Stock 11.4K Apr 15, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding LSTA Stock Option (Right to Buy) Apr 15, 2024 Common Stock 64 $580.50 Direct
holding LSTA Stock Option (Right to Buy) Apr 15, 2024 Common Stock 66 $339.00 Direct
holding LSTA Stock Option (Right to Buy) Apr 15, 2024 Common Stock 33 $94.50 Direct
holding LSTA Stock Option (Right to Buy) Apr 15, 2024 Common Stock 398 $71.55 Direct
holding LSTA Stock Option (Right to Buy) Apr 15, 2024 Common Stock 39 $53.10 Direct
holding LSTA Stock Option (Right to Buy) Apr 15, 2024 Common Stock 140 $56.85 Direct
holding LSTA Stock Option (Right to Buy) Apr 15, 2024 Common Stock 168 $74.25 Direct
holding LSTA Stock Option (Right to Buy) Apr 15, 2024 Common Stock 201 $49.20 Direct
holding LSTA Stock Option (Right to Buy) Apr 15, 2024 Common Stock 466 $23.85 Direct
holding LSTA Stock Option (Right to Buy) Apr 15, 2024 Common Stock 1.47K $13.76 Direct F2
holding LSTA Stock Option (Right to Buy) Apr 15, 2024 Common Stock 3K $3.00 Direct F3
holding LSTA Stock Option (Right to Buy) Apr 15, 2024 Common Stock 4K $3.08 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes (i) 732 restricted stock units granted on January 10, 2022 and vesting in four equal annual installments beginning on the grant date, (ii) 2,750 restricted stock units granted on January 9, 2023 and vesting in four equal annual installments beginning on the grant date, and (iii) 6,000 restricted stock units granted on January 9, 2024 and vesting in four equal annual installments beginning on the grant date.
F2 This option was granted on January 10, 2022 and vests in four equal annual installments beginning on the grant date.
F3 This option was granted on January 9, 2023 and vests in four equal annual installments beginning on the grant date.
F4 This option was granted on January 9, 2024 and vests in four equal annual installments beginning on the grant date.

Remarks:

Senior Vice President, Finance and Treasury and Chief Accounting Officer Exhibit 24.1 - Power of Attorney